| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Oct―21 |
MIP-C: A new autoimmune rheumatic disease concomitant with the COVID-19 pandemic |
Katja Brion, Mia Phillips, Antonio La Cava |
| 2 |
[GO] |
2023―Apr―18 |
COVID-19 vaccine-associated autoimmune disorders: Comments |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 3 |
[GO] |
2022―Apr―19 |
Interleukin-6 blocking therapy for COVID-19: From immune pathogenesis to clinical outcomes |
Fan Xiao, Ling Wu, Xiaoxia Zhu, Lijun Zhang, Dongzhou Liu, Lijun Wu, et al. (+2) Hejian Zou, Liwei Lu |
| 4 |
[GO] |
2022―Feb―21 |
Recommendations on SARS-CoV-2 vaccination in adult patients with rheumatic diseases |
Min Shen, Lingli Dong, Mengtao Li, Yan Zhao, Xiaofeng Zeng |
| 5 |
[GO] |
2021―Apr―16 |
Tocilizumab for severe COVID-19 pneumonia: Experience from 5 geriatric Chinese patients with 6 months follow-up |
Aihua Liu, Zhe Chen, Yongjing Cheng, Xutao Wang, Ming Gao, Cibo Huang |
| 6 |
[GO] |
2021―Apr―16 |
Systemic lupus erythematosus and coronavirus disease 2019 |
Antonio La Cava |
